Place aversion induced by blockade of μ or activation of κ opioid receptors in the dorsal periaqueductal gray matter

Behavioural Pharmacology

Volumn 11, Issue 7-8, 2000, Pages 583-589

  Sante, A B ^a   Nobre, M J ^a   Brandao, M L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Corral test; DPAG; Opioids; Place aversion; Rat; receptors; receptors

Indexed keywords

3,4 DICHLORO N METHYL N [2 (1 PYRROLIDINYL)CYCLOHEXYL]BENZENEACETAMIDE METHANESULFONATE; DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MORPHINE SULFATE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PLACE PREFERENCE; RAT; REWARD;

EID: 0033638198     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-200011000-00005     Document Type: Article

References (32)

1. A comparative study of the effects of morphine in the dorsal periaqueductal gray and nucleus accumbens of rats submitted to the elevated plus-maze test
2. Evidence that the aversive effects of opioid antagonists and κ-agonists are centrally mediated
3. Opposite motivational effects of endogenous opioids in brain and periphery
4. Opioids
5. Anatomically distract opiate receptor fields mediate reward and physical dependence
6. Involvement of opioid mechanisms in the dorsal periaqueductal gray in the drug abuse
7. GABA mediation of the anti-aversive action of the minor tranquilizers
8. Chlordiazepoxide and morphine reduce pressor response to brain stimulation in awake rats
9. Effects of morphine and midazolam on reactivity to peripheral noxious and central aversive stimuli
10. Neural substrate of defensive behavior in the midbrain tectum
11. Neurochemical mechanisms of the defensive behavior in the dorsal midbrain
12. Norbinaltorphimine: A potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo
13. Conditioned place preference in the corral: A procedure for measuring reinforcing properties of drugs
14. 3H]CTOP), a potent and highly selective peptide for mu opioid receptors in rat brain
15. Sequence-specific effects of neurokinin substance P on memory, reinforcement, and brain dopamine activity
16. Excitatory amino acids: Role in morphine excitation in rat periaqueductal gray
17. Non-stereospecific excitatory actions of morphine may be due to GABAA receptor blockade
18. Morphine applied to the mesencephalic central gray suppresses brain stimulation escape
19. Morphine injected into the periaqueductal gray attenuates brain stimulation-induced effects: An intensity discrimination study
20. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain
21. Anatomy of CNS opioid receptors
22. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
23. Aversive and anti-aversive effects of morphine in the periaqueductal gray of rats submitted to the elevated plus-maze test
24. Effects of microinjections of μ and κ receptor agonists into the dorsal periaqueductal gray of rats submitted to the plus-maze test
25. Motivational properties of kappa and mu opioid receptor agonists studied with place and taste preference conditioning
26. μ-opposing actions of the κ-opioid receptor
27. Binaltorphimine and nor-binaltorphimine, potent and selective κ-opioid receptor antagonists
28. Opioid analgesics and antagonists
29. Neurochemical and functional correlates of naltrexone-induced opiate receptor up-regulation
30. U50,488H: Selective and structurally novel non-mu (kappa) opioid agonist
31. Self-stimulation and drug reward mechanisms